PT3426226T - Composição oftalmológica - Google Patents
Composição oftalmológicaInfo
- Publication number
- PT3426226T PT3426226T PT177096419T PT17709641T PT3426226T PT 3426226 T PT3426226 T PT 3426226T PT 177096419 T PT177096419 T PT 177096419T PT 17709641 T PT17709641 T PT 17709641T PT 3426226 T PT3426226 T PT 3426226T
- Authority
- PT
- Portugal
- Prior art keywords
- ophthalmological composition
- ophthalmological
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102016203696.3A DE102016203696A1 (de) | 2016-03-07 | 2016-03-07 | Ophthalmologische Zusammensetzung |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3426226T true PT3426226T (pt) | 2022-07-20 |
Family
ID=58264510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT177096419T PT3426226T (pt) | 2016-03-07 | 2017-03-07 | Composição oftalmológica |
Country Status (15)
Country | Link |
---|---|
US (1) | US20190099441A1 (pt) |
EP (1) | EP3426226B1 (pt) |
JP (1) | JP2019511494A (pt) |
KR (1) | KR20180117635A (pt) |
CN (1) | CN108778250A (pt) |
AU (1) | AU2017231697B2 (pt) |
BR (1) | BR112018067995B1 (pt) |
CA (1) | CA3015592A1 (pt) |
DE (1) | DE102016203696A1 (pt) |
ES (1) | ES2922821T3 (pt) |
LT (1) | LT3426226T (pt) |
MX (1) | MX2018010788A (pt) |
PT (1) | PT3426226T (pt) |
RU (1) | RU2749723C2 (pt) |
WO (1) | WO2017153415A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016203696A1 (de) | 2016-03-07 | 2017-09-07 | Ursapharm Arzneimittel Gmbh | Ophthalmologische Zusammensetzung |
WO2020057548A1 (en) * | 2018-09-20 | 2020-03-26 | The Hong Kong University Of Science And Technology | Eyedrop compositions |
CN109771427A (zh) * | 2019-01-30 | 2019-05-21 | 上海克琴科技有限公司 | 一种通过提高依克多因光学纯度来增强其安全性和抗炎抗过敏活性的方法 |
EP3827818A1 (en) * | 2019-11-26 | 2021-06-02 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | Ophthalmic composition |
CN110974830A (zh) * | 2019-12-26 | 2020-04-10 | 华熙生物科技股份有限公司 | 一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途 |
CN111518627A (zh) * | 2020-05-09 | 2020-08-11 | 华熙生物科技股份有限公司 | 一种隐形眼镜护理液以及制备方法 |
DE102020112603A1 (de) * | 2020-05-10 | 2021-11-11 | Bitop Aktiengesellschaft | Kompatible Solute zur Prävention oder Behandlung von SARS-CoV-2-Infektionen |
CN111467349B (zh) * | 2020-05-14 | 2021-06-01 | 华熙生物科技股份有限公司 | 人工泪液及其制备方法 |
CN111407774B (zh) * | 2020-05-15 | 2022-03-22 | 华熙生物科技股份有限公司 | 一种眼科用组合物及其制备方法 |
CN111905094B (zh) * | 2020-06-15 | 2022-08-09 | 华熙生物科技股份有限公司 | 一种眼用组合物及其在制备用于干眼症的药物中的用途 |
CN112220102B (zh) * | 2020-09-25 | 2022-12-09 | 山东华熙海御生物医药有限公司 | 一种含透明质酸和依克多因的电子烟液及其制备方法 |
CN112480483B (zh) * | 2020-11-27 | 2022-02-01 | 华熙生物科技股份有限公司 | 一种依克多因-透明质酸复合凝胶的制备方法及所得产品 |
CN112870455B (zh) * | 2021-02-05 | 2022-05-24 | 华熙生物科技股份有限公司 | 一种含透明质酸的凝胶制剂、制法及其在内窥镜检查中的应用 |
US12012238B2 (en) * | 2021-05-26 | 2024-06-18 | Bausch + Lomb Ireland Limited | Packaging solutions |
CN116139067B (zh) * | 2021-11-22 | 2024-03-22 | 华熙生物科技股份有限公司 | 透明质酸锌形成凝胶的方法及含有透明质酸锌的滴眼凝胶及其制备 |
CN114569491B (zh) * | 2022-04-18 | 2023-08-18 | 华熙生物科技股份有限公司 | 一种抑制油脂生成的组合物及其用途 |
CN116024050A (zh) * | 2022-12-14 | 2023-04-28 | 江苏视准医疗器械有限公司 | 一种角膜接触镜保存液组合物及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4342560A1 (de) | 1993-12-14 | 1995-06-22 | Marbert Gmbh | Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten |
JP4540872B2 (ja) * | 2001-04-02 | 2010-09-08 | 株式会社資生堂 | 乾燥による皮膚傷害の抑制剤もしくは修復剤 |
DE10161149B4 (de) * | 2001-12-12 | 2007-03-08 | Ursapharm Arzneimittel Gmbh & Co. Kg | Verwendung von Heparin-haltigem Ophthalmikum |
DE10161110A1 (de) * | 2001-12-12 | 2003-06-26 | Ursapharm Arzneimittel Gmbh | Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung |
US7160560B2 (en) * | 2003-10-23 | 2007-01-09 | L'oreal S.A. | Skin-care composition |
DE102007052380A1 (de) | 2007-10-31 | 2009-05-07 | Bitop Ag | Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten |
CN101491526A (zh) * | 2009-03-03 | 2009-07-29 | 山东大学 | 四氢嘧啶在制备治疗关节炎的药物中的应用 |
DE102014007423A1 (de) * | 2014-05-22 | 2015-11-26 | Bitop Ag | Zusammensetzung zur Behandlung des Auges |
DE102016203696A1 (de) | 2016-03-07 | 2017-09-07 | Ursapharm Arzneimittel Gmbh | Ophthalmologische Zusammensetzung |
-
2016
- 2016-03-07 DE DE102016203696.3A patent/DE102016203696A1/de not_active Withdrawn
-
2017
- 2017-03-07 MX MX2018010788A patent/MX2018010788A/es unknown
- 2017-03-07 RU RU2018130713A patent/RU2749723C2/ru active
- 2017-03-07 CA CA3015592A patent/CA3015592A1/en active Pending
- 2017-03-07 EP EP17709641.9A patent/EP3426226B1/de not_active Revoked
- 2017-03-07 US US16/082,791 patent/US20190099441A1/en not_active Abandoned
- 2017-03-07 LT LTEPPCT/EP2017/055338T patent/LT3426226T/lt unknown
- 2017-03-07 KR KR1020187025990A patent/KR20180117635A/ko not_active IP Right Cessation
- 2017-03-07 CN CN201780015735.3A patent/CN108778250A/zh active Pending
- 2017-03-07 JP JP2018547451A patent/JP2019511494A/ja not_active Revoked
- 2017-03-07 AU AU2017231697A patent/AU2017231697B2/en active Active
- 2017-03-07 ES ES17709641T patent/ES2922821T3/es active Active
- 2017-03-07 BR BR112018067995-0A patent/BR112018067995B1/pt active IP Right Grant
- 2017-03-07 WO PCT/EP2017/055338 patent/WO2017153415A1/de active Application Filing
- 2017-03-07 PT PT177096419T patent/PT3426226T/pt unknown
Also Published As
Publication number | Publication date |
---|---|
WO2017153415A1 (de) | 2017-09-14 |
EP3426226A1 (de) | 2019-01-16 |
US20190099441A1 (en) | 2019-04-04 |
DE102016203696A1 (de) | 2017-09-07 |
CN108778250A (zh) | 2018-11-09 |
CA3015592A1 (en) | 2017-09-14 |
BR112018067995B1 (pt) | 2023-09-26 |
AU2017231697A1 (en) | 2018-09-13 |
RU2749723C2 (ru) | 2021-06-16 |
RU2018130713A3 (pt) | 2020-06-30 |
ES2922821T3 (es) | 2022-09-20 |
JP2019511494A (ja) | 2019-04-25 |
KR20180117635A (ko) | 2018-10-29 |
BR112018067995A2 (pt) | 2019-01-15 |
AU2017231697B2 (en) | 2022-07-07 |
MX2018010788A (es) | 2019-01-14 |
RU2018130713A (ru) | 2020-04-08 |
EP3426226B1 (de) | 2022-05-04 |
LT3426226T (lt) | 2022-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT3426226T (pt) | Composição oftalmológica | |
GB201619525D0 (en) | Ophthalmic composition | |
SG11201707117SA (en) | Ophthalmic composition | |
GB201600075D0 (en) | Immunogenci composition | |
EP3443034C0 (en) | COMPOSITION | |
GB201617908D0 (en) | Composition | |
GB201612658D0 (en) | Composition | |
GB201611782D0 (en) | Composition | |
ZA201901222B (en) | Composition comprising duddingtonia flagrans | |
GB2557410B (en) | Composition | |
GB201612359D0 (en) | Composition | |
PL3446682T3 (pl) | Kompozycja okulistyczna | |
GB201615908D0 (en) | Pharmaceautical composition | |
GB201607924D0 (en) | Composition | |
GB201620914D0 (en) | Composition | |
GB201620846D0 (en) | Composition | |
GB201620792D0 (en) | Composition | |
GB201619630D0 (en) | Composition | |
GB201618062D0 (en) | Composition | |
GB201616772D0 (en) | Composition | |
GB201616785D0 (en) | Composition | |
GB201615461D0 (en) | Composition | |
GB201615463D0 (en) | Composition | |
GB201615383D0 (en) | Composition | |
GB201615045D0 (en) | Composition |